FindTrial
Sign In

ASP3325

DRUG2 trials

Sponsors

Astellas Pharma Inc

Conditions

Chronic Kidney DiseaseHyperphosphatemia Undergoing HemodialysisPharmacokinetics of ASP3325 in Non-elderly, Healthy Adult Japanese Male and Female, and Caucasian Male Subjects

Phase 1

A Single and Multiple Oral Dose Study and a Treatment Schedule-finding Study in Non-elderly, Healthy Subjects
CompletedNCT02500953
Astellas Pharma IncPharmacokinetics of ASP3325 in Non-elderly, Healthy Adult Japanese Male and Female, and Caucasian Male Subjects
Start: 2013-07-31End: 2013-12-31Updated: 2015-07-17
Single and Multiple Dosing Study in Hemodialysis Patients With Hyperphosphatemia in Japan
CompletedNCT02510274
Astellas Pharma IncChronic Kidney Disease, Hyperphosphatemia Undergoing Hemodialysis
Start: 2014-05-12End: 2014-11-04Updated: 2024-11-05